CD4 and multiple sclerosis: Conversely, in multiple sclerosis patients, a relevant presence of EBNA1-specific CD4+ T cells, partly cross-reacting with myelin antigens (171), has been recently described, even though a direct pathogenic role for cytotoxic activity of these cells has not been demonstrated yet either in multiple sclerosis (172) or other autoimmune diseases (173, 174).